Topic: cell manufacturing
Biotech Rubius Therapeutics will invest large chunk of its recently raised $220 million to build a manufacturing facility.
Atara Biotherapeutics has initiated construction of a new CAR-T gene therapy manufacturing facility.
Lonza opened the world’s biggest manufacturing plant for cell and gene therapies targeting rare genetic disorders or life-threatening diseases.
Merck KGaA, which has been rapidly building up its manufacturing and distribution capabilities in China, says it will now expand further in Asia.
Gritstone Oncology, which focuses on personalized cancer immunotherapy, opened a new biomanufacturing facility in Pleasanton, CA, to produce the company’s first investigational products.
Bluebird Bio bought a manufacturing site in Durham, North Carolina, as it prepares to bring gene therapies to market over the next four years.
iBio, a CDMO that focuses on plant-based biotechnology, said it reached an agreement to support Aethlon Medical with the production of its blood purification device.
Swiss CDMO Lonza said it has purchased a clinical-stage manufacturing site in Hayward, California, from Shire.
Japan's Fujifilm Diosynth Biotechnologies has completed a $9 million expansion project of its cell manufacturing facilities in the U.K.
Kite Pharma's ability to handle the complex manufacturing of its CAR-T cancer treatment is one reason Gilead is paying $11.9 billion for the company.